Kuwait-Saudi Pharmaceutical Industries

Kuwait-Saudi Pharmaceutical Industries (KSPICO) is the premier pharmaceutical manufacturing entity in Kuwait, founded in 1980 to serve the healthcare needs of the Gulf region. The company produces an extensive portfolio of over 120 generic medications across diverse therapeutic categories, including cardiovascular, anti-infective, and gastrointestinal treatments. KSPICO operates a large-scale, GMP-certified manufacturing facility in the Subhan Industrial Area, capable of producing various dosage forms such as tablets, capsules, syrups, and ointments. Since its acquisition by Mezzan Holding in 2019, the company has expanded its regional footprint and continues to be a key supplier to both the public and private healthcare sectors in the Middle East.